Edit |   |
---|---|
Antigenic Specificity | CTLA4 (biosimilar) |
Clone | monoclonal |
Host Species | Recombinant |
Reactive Species | n/a |
Isotype | IgG1,kappa;kappa |
Format | purified |
Size | 0.1 mg |
Concentration | batch dependent |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | CTLA4 Biosimilar Antibody |
Immunogen | Humanized / CTLA4, PDCD1 |
Other Names | PD-1/CTLA-4 XMAB20717, PD1/CTLA4 BISPECIFIC XMAB20717, IMMUNOGLOBULIN HALF-IG G1-KAPPA/SCFV-H-CH2-CH3, (HOMO SAPIENS CTLA4 (CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4, CD152)) AND (HOMO SAPIENSPDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279)), MONOCLONAL, BISPECIFIC PD-1 X CTLA-4 DUAL CHECKPOINT INHIBITOR XMAB20717 VUDALIMAB, VUDALIMAB [INN], XMAB20717, XMAB-20717, CD; GSE; GRD4; ALPS5; CD152; CTLA-4; IDDM12; CELIAC3 |
Gene, Accession # | UniProt: P16410 |
Catalog # | orb1237908 |
Price | $855 |
Order / More Info | CTLA4 (biosimilar) Antibody from BIORBYT LTD. |
Product Specific References | n/a |
U.S. OFFICE
Biorbyt LLC
1100 Corporate Square Drive
Helix Center, Suite 221
St Louis, MO 63132
Email: info@biorbyt.com
Phone: +1 (415) 906-5211
Fax: +1 (415) 651-8558